As of November 6, 2026, 2 holders' latest Schedule 13D or 13G filings report owning 5% or more of Neuraxis, INC. The largest reported stake is Brian P. Hannasch's, at 12%. 7 filings are on record since July 1, 2025 (Schedule 13G/A, July 2, 2025).
Sell to companies like Neuraxis, INC? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Bigger Capital Fund L P · Sole voting: 0 · Shared voting: 731,377 · Sole dispositive: 0 · Shared dispositive: 731,377 · SCHEDULE 13G/A, 2026-08-03
- · Holder: Bigger Michael · Percent: 6.64% · SCHEDULE 13G/A
- · Holder: Bigger Michael · Percent: 9.17% · SCHEDULE 13G/A
- · Holder: Bigger Michael · Percent: 8.6% · SCHEDULE 13G/A
- · Holder: Bigger Michael · Percent: 6.99% · SCHEDULE 13G
Neuraxis, INC has 7 Schedule 13D or 13G filings on record since 2025-07-01. 2 holders' latest filing reports 5% or more of common stock, par value $0.001 per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| 12% | 1,144,374 | SCHEDULE 13G/A, 2025-07-02 | 2025-07-01 | |
| 6.67% | 831,729 | SCHEDULE 13G/A, 2026-08-03 | 2026-06-30 |
Holding shares or following this stake? See who's behind Neuraxis, INC and the warning signs.
Free to see. No signup.
Keep reading
More on Neuraxis, INC and the records around it.
Neuraxis, INC elsewhere on the record
Companies that share a holder
- BIGGER CAPITAL FUND L P also filed stake reports on 13 other companies: ClearPoint Neuro, Inc. (Nov 2026), Dermata Therapeutics, Inc. (Nov 2026), BTC Digital Ltd. (Oct 2026)
Watch Neuraxis, INC
Get an email when Neuraxis, INC files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Neuraxis, INC?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Neuraxis, INC: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Neuraxis, INC covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
7 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Bigger Capital Fund L P | 0 | 731,377 | 0 | 731,377 | SCHEDULE 13G/A, 2026-08-03 |
| Bigger Capital Fund GP, LLC | 0 | 731,377 | 0 | 731,377 | SCHEDULE 13G/A, 2026-08-03 |
| District 2 Capital Fund LP | 0 | 94,352 | 0 | 94,352 | SCHEDULE 13G/A, 2026-08-03 |
| District 2 Capital LP | 0 | 94,352 | 0 | 94,352 | SCHEDULE 13G/A, 2026-08-03 |
| District 2 GP LLC | 0 | 94,352 | 0 | 94,352 | SCHEDULE 13G/A, 2026-08-03 |
| District 2 Holdings LLC | 0 | 94,352 | 0 | 94,352 | SCHEDULE 13G/A, 2026-08-03 |
| Bigger Michael | 6,000 | 825,729 | 6,000 | 825,729 | SCHEDULE 13G/A, 2026-08-03 |
The latest filing identifies Neuraxis, INC by CUSIP 64134X201 and gives its principal executive office as 11611 N. MERIDIAN ST, SUITE 330, CARMEL, IN 46032 (SCHEDULE 13G/A, 2026-08-03).
What the percentages are based on
The following percentages are based on 12,477,309 shares of Common Stock issued and outstanding as of July 22, 2026, based upon the Issuer's Form S-3 filed with the Securities and Exchange Commission on July 23, 2026. As of August 3, 2026, each of Bigger Capital and Bigger GP may be deemed to beneficially own approximately 5.86% of the outstanding shares of Common Stock.Bigger Michael, SCHEDULE 13G/A, 2026-08-03
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-07-01 | Brian P. Hannasch | 7.5% | SCHEDULE 13G/A |
| 2025-07-02 | Brian P. Hannasch | 12% | SCHEDULE 13G/A |
| 2025-10-09 | Bigger Michael | 6.99% | SCHEDULE 13G |
| 2025-11-12 | Bigger Michael | 8.6% | SCHEDULE 13G/A |
| 2026-02-03 | Bigger Michael | 9.17% | SCHEDULE 13G/A |
| 2026-05-01 | Bigger Michael | 6.64% | SCHEDULE 13G/A |
| 2026-08-03 | Bigger Michael | 6.67% | SCHEDULE 13G/A |
Questions about who owns Neuraxis, INC
Who owns Neuraxis, INC?
On this page, 2 holders' latest ownership filings report 5% or more of Neuraxis, INC: Brian P. Hannasch (12%, Schedule 13G/A, filed 2025-07-02) and Bigger Michael (6.67%, Schedule 13G/A, filed 2026-08-03).
Who are the largest shareholders of Neuraxis, INC?
By the share each holder's latest filing reports, the largest holders of Neuraxis, INC on this page are Brian P. Hannasch (12%) and Bigger Michael (6.67%).
When did Brian P. Hannasch buy into Neuraxis, INC?
The filings give report dates, not purchase dates. The earliest filing from Brian P. Hannasch on this page is the Schedule 13G/A, filed 2025-07-01, reporting 7.5%; its latest, Schedule 13G/A filed 2025-07-02, reports 12%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 7 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Tools for this story
Each opens in a new tab, filled in for Neuraxis, INC. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.